Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 2018: International Consensus Conference on Outcome Measures in Rheumatology, Terrigal, Australia, May 2018 Special Interest Groups, Part 2

OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On

George A. Bruyn, Annamaria Iagnocco, Esperanza Naredo, Peter V. Balint, Marwin Gutierrez, Hilde B. Hammer, Paz Collado, Georgios Filippou, Wolfgang A. Schmidt, Sandrine Jousse-Joulin, Peter Mandl, Philip G. Conaghan, Richard J. Wakefield, Helen I. Keen, Lene Terslev and Maria Antonietta D’Agostino for the OMERACT Ultrasound Working Group
The Journal of Rheumatology October 2019, 46 (10) 1388-1393; DOI: https://doi.org/10.3899/jrheum.181095
George A. Bruyn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annamaria Iagnocco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esperanza Naredo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter V. Balint
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marwin Gutierrez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilde B. Hammer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paz Collado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgios Filippou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang A. Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Jousse-Joulin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Mandl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip G. Conaghan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Wakefield
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard J. Wakefield
Helen I. Keen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lene Terslev
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Antonietta D’Agostino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maria-antonietta.dagostino@apr.aphp.fr
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Ultrasound (US) Working Group (WG) operates research activities for the validation of US as an outcome measurement instrument according to the Filter 2.0 framework.

Methods. Original publications on definitions and scoring systems for pathophysiological manifestations and elementary lesions of various rheumatic disorders were reviewed from the onset of the WG research in 2005.

Results. Definitions and scoring systems according to new terminology are provided.

Conclusion. We have redefined OMERACT US pathology and elementary lesions as well as scoring systems, which are now proposed for OMERACT approval for application in clinical trials.

Key Indexing Terms:
  • ULTRASOUND
  • IMAGING
  • OUTCOME MEASUREMENT INSTRUMENT
  • OMERACT
  • SCORING SYSTEM
  • DEFINITIONS

Since their introduction in 20051, provisional ultrasound (US) definitions have become part of the fundamental Outcome Measures in Rheumatology (OMERACT) methodology for developing and validating US as a disease outcome measurement instrument (OMI) across various domains including inflammatory burden and structural damage2,3.

In a seminal paper, the OMERACT Ultrasound (US) Working Group (WG) described 6 provisional definitions of US lesions considered to represent an “US core set” of pathophysiological manifestations in rheumatic diseases1. The definitions were truly provisional, as at that time, a concurrent systematic literature review (SLR) highlighted the lack of consensus-based definitions in the existing literature4.

Since then, iterative validation exercises have repeatedly shown US to be a reliable OMI for measuring (ir)reversible pathophysiological manifestations of rheumatoid arthritis (RA), i.e., synovitis, tenosynovitis5,6,7, or erosions. Further, the OMERACT US WG has engaged in the validation of US as an OMI by defining US manifestations of rheumatic disorders other than RA, including osteoarthritis, spondyloarthritis (SpA), psoriatic arthritis (PsA), crystal-related arthropathies, large vessel vasculitis, Sjögren syndrome, systemic lupus erythematosus (SLE), as well as in juvenile inflammatory arthritis. The validation process not only resulted in a refinement of the original US definitions for RA pathologies but also in defining new disease-associated pathologies and corresponding elementary lesions.

This report provides an overview of the WG activities and presents the new US definitions and scoring systems for synovitis, enthesitis, tenosynovitis, and tendon damage.

Updated Definitions

Synovitis

Rather than defining a single entity, the initial definition included 2 elementary lesions, synovial effusion, and synovial hypertrophy. Either one, separate or combined, could indicate synovitis1.

Following a stepwise validation process that consisted of a Delphi exercise for developing consensual definitions of pathology and elementary lesions, Web-based and patient reliability exercises testing systematically the validity and the reliability of those lesions6,7, a sub–task force of the OMERACT US WG concluded that the old definition of synovitis was not sustainable. The “new” definition of an US-detected synovitis encompasses the whole concept of synovitis, thereby delineating synovial hypertrophy (SH) in a semiquantitative graded B mode feature and a graded Doppler mode feature. The presence of a hypoechoic SH is mandatory for defining the presence of an US-detected synovitis and for grading Doppler activity. Further, the new definition lacks the elementary lesion “synovial effusion,” because it did not prove reliable and was frequently detected in healthy subjects6,7,8. In addition, the group developed a synovitis scoring system6,7 combining B mode and Doppler mode, which demonstrated sensitivity to change in small and large joints9. The new synovitis definition is presented in Table 1, and the new definition of the related elementary lesions is reported in Table 2. The combined European League Against Rheumatism (EULAR)-OMERACT scoring system is reported in the Supplementary Table 1 (available with the online version of this article).

View this table:
  • View inline
  • View popup
Table 1.

New OMERACT definitions of US-detected pathologies.

View this table:
  • View inline
  • View popup
Table 2.

New definitions of the elementary lesions composing the US pathologies.

Enthesitis

Whereas the provisional US definition spoke of enthesopathy1, this term is now singled out exclusively for a mechanically related enthesopathy including sports-related activities10,11.

Based on an SLR, a high variability was found in the definition of enthesitis, and in particular its constituent elementary components, and no consensus-based scoring existed10. This inhomogeneity resulted in an appropriate task force to work on the development of a validated definition of enthesitis, using the same methodology described for developing synovitis11,12. The final definition of enthesitis is shown in Table 1 and can be used in SpA and PsA, along with the elementary lesions that should be detected for defining such a pathological entity (Table 2) and the scoring system to use for grading these elementary lesions12. The scoring of Doppler was further refined in a recent Delphi exercise (unpublished data) obtaining > 75% consensus on a semiquantitative scoring 0–3 (Supplementary Table 2, available with the online version of this article).

Tenosynovitis and tendon damage

Following the same systematic stepwise process, the OMERACT US WG conducted a series of formal Delphi studies and reliability exercises on elementary lesions of tenosynovitis and tendon damage, resulting in new definitions of tenosynovitis and related elementary lesions (Table 1 and Table 2), as well as 2 scoring systems, one for tenosynovitis and one for tendon damage (Supplementary Table 3, available with the online version of this article)13,14. Tendon damage is a structural lesion and solely defined in B mode, because this mode allows the evaluation of the morphology. Criterion validity of the tendon damage definition was demonstrated in cadavers15. The new definition of tenosynovitis includes changes in B mode and Doppler mode and has shown sensitivity to change in patients with RA16.

Bone erosion

The original OMERACT definition of bone erosion spoke of “an intraarticular discontinuity of the bone surface that is visible in two perpendicular planes”1. Because no new definition has been developed, this definition is still valid (Table 1)17. Future research will focus on distinguishing “true” RA erosions from other cortical breaks, e.g., vessel channels.

Osteoarthritis (OA)

Initial activities on OA started as a joint venture between the OMERACT US WG and Osteoarthritis Research International and were mainly focused on structural abnormalities in hand OA. By testing the reliability of US in defining and grading cartilage lesions and osteophytes, the group produced a dichotomous and a 4-grade semiquantitative score for cartilage damage and osteophytes, respectively (Table 2; Supplementary Table 4, available with the online version of this article)18,19. Following the work on hand OA, the group targeted other joints20.

Juvenile idiopathic arthritis (JIA)

Before defining synovitis in children, the JIA task force developed and validated definitions of normal joint components for different age groups through a Delphi consensus process and by testing them in a reliability exercise involving healthy children21,22,23,24. In contrast to the definition of synovitis in adults, the US definition in children also includes synovial effusion25. The combined scoring system for synovitis using B mode and PD mode is presented in Supplementary Table 5 (available with the online version of this article).

Gout

Following an SLR26, the group conducted a Delphi exercise with the aim of obtaining and defining the elementary components of the gouty joint27. Four definitions of elementary lesions were highlighted, i.e., double contour, aggregates, tophus, and erosions (Table 1 and Table 2), and subsequently tested for reliability in a patient-based exercise28. Future work will determine whether these elementary lesions are reliable in the development of a scoring system.

Calcium pyrophosphate crystal deposit (CPPD) disease

Although no therapeutic drugs have been specifically developed for treating CPPD disease, the WG felt that CPPD-related arthritis may be a confounding pathological manifestation. Following the OMERACT methodology, definitions of the US characteristics of CPPD at the level of fibrocartilage of the knee menisci and wrist, hyaline cartilage, tendons, and synovial fluid of the knee were obtained (Table 2; Supplementary Table 6, available with the online version of this article)29. Subsequently, a series of reliability exercises validated these elementary lesions30.

Large vessel vasculitis/giant cell arteritis (GCA)

The US appearance of normal temporal and extracranial large arteries (e.g., axillary arteries) and of respective lesions in vasculitis was defined31 (Table 2; Supplementary Table 7, available with the online version of this article). As a result of the consensus exercises, the “halo sign” and the “compression sign” are regarded as the most important US abnormalities for GCA32.

DISCUSSION

US is a unique OMI for rheumatic disease processes because it is capable of identifying both the inflammatory state and the structural damage. Starting from the 2005 preliminary definitions, novel US definitions have been developed and validated by the WG. In accordance with the Filter 3.1, the validation process of an US definition follows a stringent, step-by-step road map beginning with an SLR following the OMERACT Framework Instrument Selection Algorithm recommendations. Next is a Delphi consensus process, and image- and patient-based reliability studies33. For proof, responsiveness studies of US definition of synovitis and tenosynovitis have been carried out8,15. Along with progressive implementation of the OMI into clinical trials, patient feedback will enforce refinement of the application of US, which is in agreement with the current Filter 2.1.

The WG work is far from done. Goals now include validating US as an OMI for monitoring disease activity in Sjögren syndrome, musculoskeletal involvement of SLE, dactylitis in PsA (which remains one of the most challenging concepts to reliably identify by imaging), cartilage involvement in RA, and scleroderma. As for dactylitis, work continues on a definition of paratendinitis.

In addition to the development and validation of new US definitions of different pathologies, further research needs to delineate the (minimal) discriminatory threshold of these US pathologies. The first attempt will be to define the threshold of an active synovitis in RA. Another important future activity will be the development of a reduced joint count based on the existing EULAR-OMERACT scoring system.

We have redefined OMERACT definitions of US pathologies and elementary lesions. These updated definitions provided clarity as we completed the validation of these criteria and scoring systems, which are now proposed for approval for application in clinical trials.

ONLINE SUPPLEMENT

Supplementary material accompanies the online version of this article.

APPENDIX 1

List of study collaborators. The OMERACT Ultrasound Working Group: Sibel Aydin, Marina Backhaus, Artur Bachta, Isabelle Chary-Valckenaere, Stavros Chrysidis, Nemanja Damjanov, Bhaskar Dasgupta, Emilio Filippucci, Frederique Gandjbachkh, Andrew Filer, Stephanie Finzel, Petra Hanova, Alojzija Hocevar, Cristina Hernandez Diaz, Kei Ikeda, Nevsun Inanc, Gurjit Kaeley, Marion Kortekaas, Gavin Lee, Damien Loeuille, Silvia Magni Manzoni, Clara Malattia, Mihaela Micu, Ingrid Moller, Carlos Pineda, Viviana Ravagnani, Bethan Richards, Johannes Roth, Valentin Schäfer, Andrea delle Sedie, Marcin Skzudlarek, Nicolas Tzaribachev, Ilfita Sahbudin, Maria Stoenoiu, Giorgio Tamborrini, Violeta Vlad, Jelena Vojinovic, Ken Warrington, Daniel Windschall, Priscilla Wong, and Pascal Zuferrey.

Footnotes

  • PGC is funded in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health.

  • Accepted for publication January 18, 2019.

REFERENCES

  1. 1.↵
    1. Wakefield RJ,
    2. Balint PV,
    3. Szkudlarek M,
    4. Filippucci E,
    5. Backhaus M,
    6. D’Agostino MA,
    7. et al;
    8. OMERACT 7 Special Interest Group
    . Musculoskeletal Ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005;32:2485–7.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Boers M,
    2. Kirwan JR,
    3. Tugwell P,
    4. Beaton D,
    5. Bingham CO III,
    6. Conaghan PG,
    7. et al
    . The OMERACT Handbook. [Internet. Accessed March 21, 2019.] Available from: https://omeract.org/resources
  3. 3.↵
    1. Boers M,
    2. Kirwan JR,
    3. Wells G,
    4. Beaton D,
    5. Gossec L,
    6. d’Agostino MA,
    7. et al.
    Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745–53.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Joshua F,
    2. Lassere M,
    3. Bruyn GA,
    4. Szkudlarek M,
    5. Naredo E,
    6. Schmidt WA,
    7. et al.
    Summary findings of a systematic review of the ultrasound assessment of synovitis. J Rheumatol 2007;34:839–44.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Mandl P,
    2. Naredo E,
    3. Wakefield RJ,
    4. Conaghan PG,
    5. D’Agostino MA;
    6. OMERACT Ultrasound Task Force
    . A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 2011;38:2055–62.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. D’Agostino MA,
    2. Terslev L,
    3. Aegerter P,
    4. Backhaus M,
    5. Balint P,
    6. Bruyn GA,
    7. et al.
    Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open 2017;3:e000428.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Terslev L,
    2. Naredo E,
    3. Aegerter P,
    4. Wakefield RJ,
    5. Backhaus M,
    6. Balint P,
    7. et al.
    Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open 2017;3:e000427.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Padovano I,
    2. Costantino F,
    3. Breban M,
    4. D’Agostino MA
    . Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis 2016;75:1819–23.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. D’Agostino MA,
    2. Boers M,
    3. Wakefield RJ,
    4. Hammer H,
    5. Vittecoq O,
    6. Filippou G,
    7. et al.
    Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study. RMD Open 2016;2:e000237.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Gandjbakhch F,
    2. Terslev L,
    3. Joshua F,
    4. Wakefield RJ,
    5. Naredo E,
    6. D’Agostino MA;
    7. OMERACT Ultrasound Task Force
    . Ultrasound in the evaluation of enthesitis: status and perspectives. Arthritis Res Ther 2011;13:R188.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Terslev L,
    2. Naredo E,
    3. Iagnocco A,
    4. Balint PV,
    5. Wakefield RJ,
    6. Aegerter P,
    7. et al;
    8. Outcome Measures in Rheumatology Ultrasound Task Force
    . Defining enthesitis in spondyloarthritis by ultrasound: results of a Delphi process and of a reliability reading exercise. Arthritis Care Res 2014;66:741–8.
    OpenUrl
  12. 12.↵
    1. Balint PV,
    2. Terslev L,
    3. Aegerter P,
    4. Bruyn GA,
    5. Chary-Valckenaere I,
    6. Gandjbakhch F,
    7. et al;
    8. OMERACT Ultrasound Task Force members
    . Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative. Ann Rheum Dis 2018;77:1730–5.
    OpenUrl
  13. 13.↵
    1. Naredo E,
    2. D’Agostino MA,
    3. Wakefield RJ,
    4. Möller I,
    5. Balint PV,
    6. Filippucci E,
    7. et al;
    8. OMERACT Ultrasound Task Force
    . Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis. Ann Rheum Dis 2013;72:1328–34.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Bruyn GA,
    2. Hanova P,
    3. Iagnocco A,
    4. D’Agostino MA,
    5. Möller I,
    6. Terslev L,
    7. et al;
    8. OMERACT Ultrasound Task Force
    . Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Ann Rheum Dis 2014;73:1929–34.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Janta I,
    2. Morán J,
    3. Naredo E,
    4. Nieto JC,
    5. Uson J,
    6. Möller I,
    7. et al.
    How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage? Rheumatol Int 2016;36:863–9.
    OpenUrl
  16. 16.↵
    1. Ammitzbøll-Danielsen M,
    2. Østergaard M,
    3. Naredo E,
    4. Terslev L
    . Validity and sensitivity to change of the semi-quantitative OMERACT ultrasound scoring system for tenosynovitis in patients with rheumatoid arthritis. Rheumatology 2016;55:2156–66.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Szkudlarek M,
    2. Terslev L,
    3. Wakefield RJ,
    4. Backhaus M,
    5. Balint PV,
    6. Bruyn GA,
    7. et al.
    Summary findings of a systematic literature review of the ultrasound assessment of bone erosions in rheumatoid arthritis. J Rheumatol 2016;43;12–21.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Hammer HB,
    2. Iagnocco A,
    3. Mathiessen A,
    4. Filippucci E,
    5. Gandjbakhch F,
    6. Kortekaas MC,
    7. et al.
    Global ultrasound assessment of structural lesions in osteoarthritis: a reliability study by the OMERACT ultrasonography group on scoring cartilage and osteophytes in finger joints. Ann Rheum Dis 2016;75:402–7.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Iagnocco A,
    2. Conaghan PG,
    3. Aegerter P,
    4. Möller I,
    5. Bruyn GA,
    6. Chary-Valckenaere I,
    7. et al.
    The reliability of musculoskeletal ultrasound in the detection of cartilage abnormalities at the metacarpo-phalangeal joints. Osteoarthritis Cartilage 2012;20:1142–6.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Bruyn GA,
    2. Naredo E,
    3. Damjanov N,
    4. Bachta A,
    5. Baudoin P,
    6. Hammer HB,
    7. et al;
    8. Ultrasound Task Force
    . An OMERACT reliability exercise of inflammatory and structural abnormalities in patients with knee osteoarthritis using ultrasound assessment. Ann Rheumatic Dis 2016;75:842–6.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Roth J,
    2. Jousse-Joulin S,
    3. Magni-Manzoni S,
    4. Rodriguez A,
    5. Tzaribachev N,
    6. Iagnocco A,
    7. et al;
    8. Outcome Measures in Rheumatology Ultrasound Group
    . Definitions for the sonographic features of joints in healthy children. Arthritis Care Res 2015;67:136–42.
    OpenUrlCrossRef
  22. 22.↵
    1. Collado P,
    2. Windschall D,
    3. Vojinovic J,
    4. Magni-Manzoni S,
    5. Balint P,
    6. Bruyn GAW,
    7. et al;
    8. OMERACT ultrasound subtask force on pediatric
    . Amendment of the OMERACT ultrasound definitions of joints’ features in healthy children when using the DOPPLER technique. Pediatr Rheumatol Online J 2018;16:23.
    OpenUrl
  23. 23.↵
    1. Windschall D,
    2. Collado P,
    3. Vojinovic J,
    4. Magni-Manzoni S,
    5. Balint P,
    6. Bruyn GAW,
    7. et al;
    8. OMERACT paediatric ultrasound subtask force
    . Age-related vascularization and ossification in joints in children: an international pilot study to test the multi-observer ultrasound reliability. Arthritis Care Res 2017 Aug 4 (E-pub ahead of print).
  24. 24.↵
    1. Collado P,
    2. Vojinovic J,
    3. Nieto JC,
    4. Windschall D,
    5. Magni-Manzoni S,
    6. Bruyn GA,
    7. et al;
    8. OMERACT Ultrasound Pediatric Group
    . Toward standardized musculoskeletal ultrasound in pediatric rheumatology: normal age-related ultrasound findings. Arthritis Care Res 2016;68:348–56.
    OpenUrl
  25. 25.↵
    1. Roth J,
    2. Ravignani V,
    3. Backhaus M,
    4. Balint P,
    5. Bruns A,
    6. Bruyn GA,
    7. et al;
    8. OMERACT Ultrasound Group
    . Preliminary definitions for the sonographic features of synovitis in children. Arthritis Care Res 2017;69:1217–23.
    OpenUrl
  26. 26.↵
    1. Chowalloor PV,
    2. Keen HI
    . A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia. Ann Rheum Dis 2013;72:638–45.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Gutierrez M,
    2. Schmidt WA,
    3. Thiele R,
    4. Keen H,
    5. Kaeley G,
    6. Naredo E,
    7. et al;
    8. OMERACT Ultrasound Gout Task Force group
    . International consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise. Rheumatology 2015;54:1797–805.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Terslev L,
    2. Gutierrez M,
    3. Christensen R,
    4. Balint PV,
    5. Bruyn GA,
    6. Delle Sedie A,
    7. et al;
    8. OMERACT US Gout Task Force
    . Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise. J Rheumatol 2015;42:2149–54.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Filippou G,
    2. Scirè CA,
    3. Damjanov N,
    4. Adinolfi A,
    5. Carrara G,
    6. Picerno V,
    7. et al.
    Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force. J Rheumatol 2017;44:1744–9.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Filippou G,
    2. Scirè CA,
    3. Adinolfi A,
    4. Damjanov N,
    5. Carrara G,
    6. Bruyn GAW,
    7. et al.
    Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force. Ann Rheumatic Dis 2018;77:1194–8.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Chrysidis S,
    2. Duftner C,
    3. Dejaco C,
    4. Schäfer VS,
    5. Ramiro S,
    6. Carrara G,
    7. et al.
    Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT large vessel vasculitis ultrasound working group. RMD Open 2018;4:e000598.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Schäfer VS,
    2. Chrysidis S,
    3. Dejaco C,
    4. Duftner C,
    5. Iagnocco A,
    6. Bruyn GA,
    7. et al.
    Assessing vasculitis in giant cell arteritis by ultrasound: results of OMERACT patient-based reliability exercises. J Rheumatol 2018;45:1289–95.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Terslev L,
    2. Naredo E,
    3. Keen HI,
    4. Bruyn GA,
    5. Iagnocco A,
    6. Wakefield RJ,
    7. et al.
    The OMERACT stepwise approach to select and develop imaging outcome measurement instruments: the musculoskeletal ultrasound example. J Rheumatol 2019;46:1394–1400.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 10
1 Oct 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On
George A. Bruyn, Annamaria Iagnocco, Esperanza Naredo, Peter V. Balint, Marwin Gutierrez, Hilde B. Hammer, Paz Collado, Georgios Filippou, Wolfgang A. Schmidt, Sandrine Jousse-Joulin, Peter Mandl, Philip G. Conaghan, Richard J. Wakefield, Helen I. Keen, Lene Terslev, Maria Antonietta D’Agostino
The Journal of Rheumatology Oct 2019, 46 (10) 1388-1393; DOI: 10.3899/jrheum.181095

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On
George A. Bruyn, Annamaria Iagnocco, Esperanza Naredo, Peter V. Balint, Marwin Gutierrez, Hilde B. Hammer, Paz Collado, Georgios Filippou, Wolfgang A. Schmidt, Sandrine Jousse-Joulin, Peter Mandl, Philip G. Conaghan, Richard J. Wakefield, Helen I. Keen, Lene Terslev, Maria Antonietta D’Agostino
The Journal of Rheumatology Oct 2019, 46 (10) 1388-1393; DOI: 10.3899/jrheum.181095
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • DISCUSSION
    • ONLINE SUPPLEMENT
    • APPENDIX 1
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

ULTRASOUND
IMAGING
OUTCOME MEASUREMENT INSTRUMENT
OMERACT
SCORING SYSTEM
DEFINITIONS

Related Articles

Cited By...

More in this TOC Section

  • Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group
  • Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018
  • Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group
Show more OMERACT 2018: International Consensus Conference on Outcome Measures in Rheumatology, Terrigal, Australia, May 2018 Special Interest Groups, Part 2

Similar Articles

Keywords

  • ultrasound
  • imaging
  • OUTCOME MEASUREMENT INSTRUMENT
  • OMERACT
  • scoring system
  • DEFINITIONS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire